可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Franco CA , Gennari C, Nami R, et al. Cardiovascular effects of calcitonin gene-related peptide I and II in man [J]. Circ Res, 1987, 60: 393.
[2] Tanirisa Y, Frishman WH, Kumar A. Endothelin and endothelin antagonism: Role in cardiovascular health and disease [J]. Am Heart J, 1995, 130 (3, Part 1) : 501.
[3] Lappe RW. Hemodynamic effects of calcitonin gene-related peptide in consicous rats[J]. Regulpept, 1987, 19: 307.
[4] Yoshiyu T, Isamu M, Wu PS, et al. Effects of an endothelin receptor antagonistin rats with cyclosporine-induced hypertension[J]. Hypertension, 1995, 26: 932.
[5] Ryoyu T, Isamu M. endocrine and auto-paracrine factors in the pathogenesis of primary hypercension[J]. Hypertens Res, 1995, 18: 171.
[6] 李红梅, 裴建明, 朱妙章, 等. 降钙素基因相关肽的抗室颤作用[J]. 心功能杂志, 1997, 9 (1) : 5.
[7] Gangule PR, Supowit SC, Winmalawansu SJ , et al. calcitonin gene-related peptide is a depressor in NG-nitro-L-arginine methyl ester-induced hypertension during pregnancy [J]. Hypertension, 1997, 29 (1 pt 2) : 248.
[8] 吴宏超, 钱学贤, 李立平. 降钙素基因相关肽对顿抑心肌心功能的影响[J]. 心功能杂志, 1999, 11 (4) : 220.